Phase 4 Heart Disease Trial, Recruiting NCT06578234 Sponsor: Region Skane Condition: Heart Disease
Back to Heart Disease

Phase 4 Heart Disease Trial, Recruiting

NCT06578234
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients being assessed for heart conditions:

  • The person has agreed in writing to take part in the trial
  • The person has been referred to the Department of Clinical Physiology at Skåne University Hospital for a suspected or confirmed chronic coronary condition or heart failure
  • The person falls within the required age and sex balance — the trial is looking for equal numbers of men and women in each decade of age from 40 years old up to over 80 years old
  • The person either has no known heart failure, or has a known heart failure diagnosis (two separate groups)
  • The person has not had any caffeine in the 24 hours before the examination

For healthy volunteers:

  • The person has agreed in writing to take part in the trial
  • The person falls within the required age and sex balance — equal numbers of men and women in each decade of age from 40 years old up to over 80 years old
  • The person has not had any caffeine in the 24 hours before the examination

Who may not be able to join:

For patients:

  • The person has been referred as an emergency or is currently admitted as an inpatient
  • The person is currently in an unstable medical condition
  • The person is experiencing acute (sudden or severe) chest pain
  • The person has severe or currently worsening heart failure
  • The person has an irregular heart rhythm, such as atrial fibrillation, rather than a normal sinus rhythm
  • The person has asthma or severe chronic lung disease
  • The person has known long-term kidney disease with significantly reduced kidney function (eGFR below 45mL/min/1.73m²) (confirm with trial site)
  • The person has a specific type of heart conduction problem known as AV-block grade II or III (confirm with trial site)
  • The person has a heart conduction problem called Left Bundle Branch Block (confirm with trial site)
  • The person has a resting blood pressure that is either too low (below 90 mmHg systolic) or too high (above 230 mmHg systolic)
  • The person has raised pressure inside the skull
  • The person has a known allergy or previous bad reaction to the medications adenosine or mannitol
  • The person has a known allergy or previous bad reaction to gadolinium contrast dye used in MRI scans
  • The person is currently taking medication that contains dipyridamole, theophylline, or related compounds (confirm with trial site)
  • The person experiences claustrophobia (fear of enclosed spaces)
  • The person has a medical device in their body that is not safe for MRI scanning, such as a pacemaker, certain implants, or clips in the brain
  • The person is pregnant or breastfeeding (assessed by self-reported questions only)
  • The person is unable to give informed consent due to their mental state, language barriers, or similar reasons

For healthy volunteers, all of the above apply, plus:

  • The person has a blood pressure reading above 140/90, measured using standard clinical methods
  • The person has a known ongoing condition affecting the whole body (systemic disease)
  • The person has any known heart condition
  • The person is currently taking any medication for the heart or blood vessels
  • The person is currently taking any medication that could affect heart or blood vessel health
  • The person smokes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 046171000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Region Skane
Registry
ClinicalTrials.gov
Start date
23 October 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Myocardial hyperemia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov